NCT04891198 2026-03-25ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors3D MedicinesPhase 2 Recruiting126 enrolled
NCT07327411 2026-01-08Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid TumorsSecond Affiliated Hospital of Soochow UniversityPhase 2 Not yet recruiting40 enrolled